Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 70 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1843. Clear
Clear
Q3
HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY for HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY
3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy
View → Q3
FAEGRE DRINKER BIDDLE & REATH LLP for TEVA PHARMACEUTICALS USA, INC.
3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $60,000.00 income
Health Issues, Copyright/Patent/Trademark
View → Q3
BLUECROSS BLUESHIELD OF TENNESSEE for BLUECROSS BLUESHIELD OF TENNESSEE
3rd Quarter (July 1 - Sep 30) 2025 · Tennessee · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy
View → Q3
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $90,000.00 income
Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark
View → Q3
BCBSM, INC. for BCBSM INC
3rd Quarter (July 1 - Sep 30) 2025 · Minnesota · House · Senate
Health Issues, Budget/Appropriations, Pharmacy
View → Q2
VIATRIS INC. for VIATRIS INC
2nd Quarter (Apr 1 - June 30) 2025 · Pennsylvania · House · Senate
Health Issues, Copyright/Patent/Trademark, Trade (domestic/foreign), Financial Institutions/Investments/Securities
View → Q2
WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Copyright/Patent/Trademark, Pharmacy
View → Q2
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $90,000.00 income
Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark
View → Q2
ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Pharmacy, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)
View → Q2
S-3 GROUP for VIATRIS (MYLAN, INC)
2nd Quarter (Apr 1 - June 30) 2025 · Pennsylvania · House · Senate · $60,000.00 income
Health Issues, Copyright/Patent/Trademark
View → Q2
BLUECROSS BLUESHIELD OF TENNESSEE for BLUECROSS BLUESHIELD OF TENNESSEE
2nd Quarter (Apr 1 - June 30) 2025 · Tennessee · House · Senate
Pharmacy, Medicare/Medicaid, Health Issues
View → Q2
FAEGRE DRINKER BIDDLE & REATH LLP for TEVA PHARMACEUTICALS USA, INC.
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $60,000.00 income
Health Issues, Copyright/Patent/Trademark
View → Q1
VIATRIS INC. for VIATRIS INC
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate
Health Issues, Copyright/Patent/Trademark, Trade (domestic/foreign), Financial Institutions/Investments/Securities
View → 1A
S-3 GROUP for VIATRIS (MYLAN, INC)
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $60,000.00 income
Health Issues
View → Q1
S-3 GROUP for VIATRIS (MYLAN, INC)
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $40,000.00 income
Health Issues
View → Q1
WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Copyright/Patent/Trademark, Pharmacy
View → RR
S-3 GROUP for VIATRIS (MYLAN, INC)
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania
Health Issues
View → Q1
FAEGRE DRINKER BIDDLE & REATH LLP for TEVA PHARMACEUTICALS USA, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate · $60,000.00 income
Health Issues, Copyright/Patent/Trademark
View → Q1
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $90,000.00 income
Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark
View → Q1
ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Pharmacy, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Previous Page 3 of 3

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem